Skip to main content
. 2021 Apr 30;100(17):e25648. doi: 10.1097/MD.0000000000025648

Table 1.

Characteristics of the included studies.

First Author Year Country Study type Approach Cases Age (yr) Male BMI (kg/m2) Malignant Tumor size (mm) ASA (1/2/3/4) NOS
Tranchart 2014 France Retro/ RH 28 66.5 (42–84) 13 26.1 (16.7–36) 15 35 (6–115) 5/14/9 7
Comparative LH 28 66 (41–78) 13 23.2 (16–33) 17 40 (6–130) 5/19/4
Salloum 2016 France Retro/ RLLS 16 56 ± 15 8 27 ± 5 9 56 < 2,24 > 2 7
Case-control LLLS 80 58 ± 16 38 26 ± 5 48 10 < 2,6 > 2
Montalti 2015 Italy Retro/ RPS 36 62 ± 13 21 NA 26 44.4 ± 30.6 3/19/13 7
Comparative LPS 72 56.8 ± 15 39 NA 50 49.5 ± 35 10/42/20
Berber 2010 USA Retro/ RH 9 66.6 ± 6.4 7 NA 7 32 ± 13 NA 9
Comparative LH 23 66.7 ± 9.6 12 NA 21 29 ± 13 NA
Minggen HU 2019 China Retro/ RLLS 58 52.2 ± 13.8 33 24.7 ± 4.0 31 47 ± 26 2/54/2 8
Case-control LLLS 54 48.9 ± 13.1 26 23.8 ± 3.2 26 47 ± 28 5/48/1
Kim 2016 Korea Retro/ RLLS 12 54.1 ± 12.2 6 NA 7 23 (20–36) NA 8
Case-contro LLLS 31 56.4 ± 11.6 18 NA 24 24 (17–30) NA
O’Connor 2017 USA Retro/ RH 39 NA NA NA NA 40 (17–110) NA 7
Comparative LH 50 NA NA NA NA 4 (10–95) NA
Lai 2013 China Retro/ RH 33 NA NA NA NA NA NA 7
Comparativel LH 33 NA NA NA NA NA NA
Lee 2015 China Retro/ RLLS 38 58.5 (20–81) 26 NA 27 30 (11–120) 4/31/3 8
Case-control LLLS 29 60 (34–80) 15 NA 23 30 (15–70) 6/26/3
Croner 2016 Germany Retro/ RH 10 64 (45–76) 8 28 (28.3) 10 NA 1 4/4 8
Case-control LH 19 59 (32–85) 13 26 (26.6) 15 NA 2/7/9/1
Ruoyu 2018 China Retro/ RLLS 7 NA NA NA NA NA NA 7
Comparativel LLLS 17 NA NA NA NA NA NA
Packiam 2012 USA Retro/ RLLS 11 57 ± 16 3 31 ± 7 6 55 (24–65) NA 7
Comparative LLLS 18 52 ± 17 4 29 ± 7 8 44 (26–71) NA